Freddy A. Jimenez
General Counsel, Celldex Therapeutics.
Companies
- Celldex TherapeuticsGeneral counsel Jan 4, 2021 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Celldex Therapeutics CLDX30,796 shares2$910.0K at $29.55Dec 4, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 4, 2025Sold 4,166 shares at $29.10 of Celldex Therapeutics2
- Aug 13, 2025Sold 430 shares at $25.42 of Celldex Therapeutics3
- Aug 13, 2025Sold 341 shares at $23.95 of Celldex Therapeutics3
- Jun 5, 2024Exercised options 9,540 shares at $10.38 of Celldex Therapeutics4
- Jun 3, 2024Sold 8,006 shares at $33.60 of Celldex Therapeutics5
- Jun 3, 2024Exercised options 8,006 shares at $10.38 of Celldex Therapeutics5
- Feb 13, 2024Exercised options 20,000 shares at $2.78 of Celldex Therapeutics6
- Feb 13, 2024Exercised options 4,166 shares at $9.02 of Celldex Therapeutics6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Aug 15, 2025
- 4SEC EDGARForm 4 filed Jun 7, 2024
- 5SEC EDGARForm 4 filed Jun 5, 2024
- 6SEC EDGARForm 4 filed Feb 15, 2024